Psychologist Phil Hickey, writing about the CAFE study in which Dan markingson died, states:
"Given that the study was funded by Astra Zeneca (the manufacturer of quetiapine), it is very difficult
to avoid the conclusion that the purpose of CAFE was simply to rescue
Astra Zeneca’s product from the negative findings of CATIE. It looks more like marketing than research."
"In this regard, it is perhaps worth noting that in 90% of drug trials
that are funded by a pharmaceutical company, the sponsor’s product is
found to be superior to the competitor’s product. (Heres et al 2006)."
Read the rest of his excellent post here.